CARsgen Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $186M
Latest Deal Amount
  • Investors
  • 12

CARsgen Therapeutics General Information

Description

Developer of CAR-T cell therapy designed to focus on treating solid tumor. The company's CAR-T cell therapy uses antigen receptor T-cell (CAR-T) therapeutics to fight against tumor with a perspective to cure cancer, enabling physicians to deliver safe, effective and accessible treatments for patients.

Contact Information

Website
www.carsgen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Drug Discovery
Primary Office
  • 1F, Building 2, Number 466 Yindu Road
  • Xuhui District
  • Shanghai, 200231
  • China
+86 021 0000 0000

CARsgen Therapeutics Timeline

2018201920202021
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CARsgen Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 30-Sep-2020 $186M 00000 Completed Generating Revenue
4. Early Stage VC 02-Mar-2018 0000 000.00 Completed Clinical Trials - Phase 1
3. Early Stage VC (Series B) 25-Jan-2016 0000 000.00 Completed Startup
2. Early Stage VC (Series A) 26-Nov-2014 $1.63M $1.63M Completed Startup
1. Accelerator/Incubator 05-Dec-2019 Completed Clinical Trials - Phase 1
To view CARsgen Therapeutics’s complete valuation and funding history, request access »

CARsgen Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
Zonghai Li MD Co-Founder, Chairman, Chief Executive Officer and Chief Scientific Officer
Huamao Wang Ph.D Chief Operating Officer & Co-Founder
Haiou Chen Executive Vice President, Financial & HR
Leigh Hsu Ph.D Senior Vice President, Business Development
Jie Jia Ph.D Vice President, Strategic Alliances and Operations
You’re viewing 5 of 7 executive team members. Get the full list »

CARsgen Therapeutics Board Members (2)

Name Representing Role Since
Chi Hyun KTB Ventures Board Member 000 0000
Zonghai Li MD CARsgen Therapeutics Co-Founder, Chairman, Chief Executive Officer and Chief Scientific Officer 000 0000
To view CARsgen Therapeutics’s complete board members history, request access »

CARsgen Therapeutics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Lilly Asia Ventures Venture Capital Minority 000 0000 000000 0
Loyal Valley Capital Growth/Expansion Minority 000 0000 000000 0
Shiyu Capital Venture Capital Minority 000 0000 000000 0
South China Venture Capital Growth/Expansion Minority 000 0000 000000 0
Summer Capital (China) Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »